CISPLATIN NEPHROTOXICITY
Clinical trials for CISPLATIN NEPHROTOXICITY explained in plain language.
Never miss a new study
Get alerted when new CISPLATIN NEPHROTOXICITY trials appear
Sign up with your email to follow new studies for CISPLATIN NEPHROTOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Diabetes drug may shield kidneys from chemo damage
Disease control Recruiting nowThis study tests if dapagliflozin, a drug used for diabetes, can prevent kidney damage in people receiving platinum-based chemotherapy for solid tumors. About 46 participants will receive either dapagliflozin or a placebo, and researchers will measure kidney injury markers in uri…
Matched conditions: CISPLATIN NEPHROTOXICITY
Phase: PHASE2 • Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran • Aim: Disease control
Last updated May 26, 2026 12:05 UTC
-
Kidney shield? antioxidant supplement tested in chemo patients
Symptom relief Recruiting nowThis study tests whether alpha-lipoic acid, a natural antioxidant, can protect the kidneys of cancer patients receiving cisplatin chemotherapy. About 50 adults with solid tumors will take either alpha-lipoic acid or a placebo alongside their chemo. The goal is to see if the suppl…
Matched conditions: CISPLATIN NEPHROTOXICITY
Phase: PHASE2 • Sponsor: Minia University • Aim: Symptom relief
Last updated May 18, 2026 12:01 UTC